Lung cancer cell lines resistant to cisplatin were reported to have a higher expression of AURKA and AURKA inhibition; in addition, cisplatin led to increased cytotoxicity in NSCLC cell lines [23]. This evidence concerns the gene AURKA and lung carcinoma.